Raltegravir Pharmacokinetics in Neonates Following Maternal Dosing-Reference-Cited by-同舟云学术

Raltegravir Pharmacokinetics in Neonates Following Maternal Dosing

Published:2014-11-01 Issue:3 Volume:67 Page:310-315
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Clarke Diana F.,Acosta Edward P.,Rizk Matthew L.,Bryson Yvonne J.,Spector Stephen A.,Mofenson Lynne M.,Handelsman Edward,Teppler Hedy,Welebob Carolee,Persaud Deborah,Cababasay Mae P.,Wang JiaJia,Mirochnick Mark

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference13 articles.

1. . Absence of detectable HIV-1 viremia after treatment cessation in an infant.;Persaud;N Engl J Med,2013

2. . Three postpartum antiretroviral regimens to prevent intrapartum HIV infection.;Nielsen-Saines;N Engl J Med,2012

3. Raltegravir: a review of its pharmacokinetics, pharmacology and clinical studies.;Burger;Expert Opin Drug Metab Toxicol,2010

4. . Raltegravir in vitro effect on bilirubin binding.;Clarke;Pediatr Infect Dis J,2013

5. . Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjects.;Iwamato;Clin Pharmacol Ther,2008

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human immunodeficiency virus/acquired immunodeficiency syndrome in the infant;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Impact of Genetic Variants in ABCG2, NR1I2, and UGT1A1 on the Pharmacokinetics of Dolutegravir in Children;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-03-01

3. HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment;Pharmaceuticals;2022-12-09

4. Placental transfer and vascular effects of pharmaceutical drugs in the human placenta ex vivo: A review;Placenta;2022-05

5. Virus infection and direct-acting antivirals in pregnancy;Clinical and Experimental Obstetrics & Gynecology;2022-04-13